ArticleThe Journal of urology2020

Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.

Chana Weinstock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.